LeoMed

Changzhou, China Founded: 2011 • Age: 15 yrs
Developer of Vascular and Gastrointestinal medical devices
Annual revenue - Latest available
Total funding $15.5M 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About LeoMed

LeoMed is a company based in Changzhou (China) founded in 2011. LeoMed has raised $15.47 million across 2 funding rounds from investors including CICC and Cowin Capital. LeoMed operates in a competitive market with competitors including Creo Medical, Torax Medical, SafeHeal, HyGIeaCare and Lexington Medical, among others.

  • Headquarter Changzhou, China
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $15.47 M (USD)

    in 2 rounds

  • Latest Funding Round
    $15.47 M (USD), Series A

    Jun 28, 2021

  • Investors
    CICC

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of LeoMed

LeoMed has successfully raised a total of $15.47M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.47 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in LeoMed

LeoMed has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include CICC and Cowin Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Diversified asset management and corporate advisory services are provided.
Locked Locked Locked
Premium access

Investor details for LeoMed

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by LeoMed

Investments
Premium access

Investment portfolio details for LeoMed

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - LeoMed

Premium access

Detailed financials for LeoMed

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Leomed Comparisons

LeoMed Primary company
Description
Developer of Vascular and Gastrointestinal medical devices
Location
Changzhou, China
Founded Year
2011
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for LeoMed

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of LeoMed

LeoMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Creo Medical, Torax Medical, SafeHeal, HyGIeaCare and Lexington Medical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of electrosurgical system and range of flexible endoscopic instruments
Locked Locked Locked
Products to restore human sphincter function
Locked Locked Locked
A medical device for colorectal surgery complications is developed.
Locked Locked Locked
Provides a specialized device for effective colonoscopy preparation.
Locked Locked Locked
Abdominal surgical instruments are developed for medical procedures.
Premium access

Detailed competitors of LeoMed

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Leomed

Premium access

Complete news archive for LeoMed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LeoMed

LeoMed was founded in 2011 and raised its 1st funding round 3 years after it was founded.

LeoMed is headquartered in Changzhou, China. It is registered at Changzhou, Jiangsu, China.

LeoMed is a funded company, having raised a total of $15.47M across 2 funding rounds to date.

Developer of Vascular and Gastrointestinal medical devices. Its Gastrointestinal portfolio includes devices such as Ligation Devices, Single-use Guide Wires, Single-use Balloon Dilatation Catheter, Sphincterotome, Single-use Stone Retrieval Ballon, Disposable biopsy forceps, etc.

LeoMed's top competitors include Creo Medical, SafeHeal and Lexington Medical.

LeoMed has 2 investors. Key investors include CICC, and Cowin Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available